Based on ex vivo and in vivo studies, Choong et al. (2021) indicated that influencing islet peptide tyrosine tyrosine (PYY (1–36)) through NPY1R dependence improves glucose homeostasis in patients with type 2 diabetes. This evidence concerns the gene NPY1R and type 2 diabetes mellitus.